Argentina Neurology Devices Market Report 2022 to2030

Argentina Neurology Devices Market Analysis

$ 3999

Argentina's Neurology Device Market is expected to witness growth from $xx Bn in 2022 to $xx Bn in 2030 with a CAGR of xx% for the forecasted year 2022-2030. The demand for neurology devices is rising in Argentina as neurological diseases are becoming more common. This includes ailments like multiple sclerosis, Parkinson's disease, seizures, and stroke, among others. The market is segmented by product type and by the end user. Some key players in this market include Johnson and Johnson, GE Healthcare, Stryker, Medtronic, Abbott Laboratories, and Philips Healthcare.

ID: IN10ARMD012 CATEGORY: Medical Devices GEOGRAPHY: Argentina AUTHOR: Jigyasu Bhandari

Buy Now

Argentina Neurology Devices Market Executive Analysis

Argentina Neurology Devices Market size is at around $xx Bn in 2022 and is projected to reach $xx Mn in 2030, exhibiting a CAGR of xx% during the forecast period. Argentina typically spends 10% of its GDP on healthcare, which is among the highest rates in the area. In Argentina, imports make up between 70%-75% of the market for medical devices and equipment. The United States typically controls between 20% -25% of the market.

In Argentina, Neurological diseases affected 8.8% of the total population. Stroke (7.4%), dementia (8.6%), and migraine (17.9%) were the most prevalent brain conditions. Multiple Sclerosis (MS), Parkinson's disease, and epilepsy were some other prevalent brain conditions. In Argentina, there are 200 incidences of Parkinson's disease for every 100,000 people. 7.6 out of every 1,000 people in Argentina had epilepsy. 8.4 instances of Multiple Sclerosis (MS) were found for every 100,000 people in Argentina. In research studies to better comprehend neurological disorders and create novel treatments, neurology devices are used in Argentina. TMS and EEG devices are two examples of tools used in studies to look into the neural processes underlying different neurological disorders. In Argentina, Neurology Devices are used to track the development of the illness and the effectiveness of treatment. For instance, EEG and EMG devices are used to assess, respectively, the efficacy of treatments for epilepsy and neuromuscular diseases. Imaging technology is used to track the development of diseases like brain tumors and multiple sclerosis (MS).

Market Dynamics

Market Growth Drivers

The demand for neurology devices is rising in Argentina as neurological diseases are becoming more common. This includes ailments like multiple sclerosis, Parkinson's disease, seizures, and stroke, among others. The market for neurology devices is being driven by Argentina's growing elderly population. As people get older, they have a greater chance of getting neurological conditions like dementia, Alzheimer's, and Parkinson's. The demand for newer, more sophisticated devices in Argentina is being driven by technological developments in neurology devices. For instance, improvements in imaging technology have produced more precise and accurate imaging systems that are used to identify and track neurological diseases.

Market Restraints

In Argentina, reimbursement for neurology devices might be constrained, which can make it challenging for medical professionals and patients to obtain these devices. The ability of manufacturers to offer their products on the market may be restricted by limited reimbursement. The Argentine market for neurology devices may also be constrained by regulatory issues. A manufacturer's ability to sell their products on the market may be constrained if they have trouble getting regulatory clearance for their devices.

Competitive Landscape

Key Players

Philips Healthcare
Medtronic
Abbott Laboratories
Johnson & Johnson
Boston Scientific
Nihon Kohden
GE Healthcare
Stryker

Notable Recent Deals

2020: To distribute Neurosoft's EEG and EMG systems in Argentina, Grupo Gamma, an Argentine distributor of medical technology, revealed a partnership with Neurosoft (a Russian company) in 2020.

2020: To support and provide training for deep brain stimulation (DBS) procedures, top medical device manufacturer Medtronic revealed a partnership with Hospital Universitario Austral in Buenos Aires in 2020.

Healthcare Policies and Regulatory Landscape

A Regulatory structure for Neurology devices exists in Argentina. The National Administration of Drugs, Food, and Medical Technology (ANMAT) is Argentina's governing body in charge of monitoring neurology devices. In Argentina, the safety, effectiveness, and quality of neurology devices are governed by ANMAT. The regulatory approval of ANMAT is required for manufacturers to sell neurology devices in Argentina. An application must be submitted as part of the clearance process, and it must contain data on the device's efficacy and safety as well as details on its production and quality control procedures. A device may be distributed in the Argentine market once it has received approval. The market for neurology devices in Argentina is influenced by healthcare policies in addition to governmental approval. The Argentina government has put in place a number of programmes to enhance access to and the quality of the country's healthcare system, including neurology treatment. For instance, the National Neurological Disease Plan was introduced in 2015 with the aim of enhancing neurological disease diagnosis, management, and therapy. The strategy calls for expanding the number of facilities with a focus on neurological care as well as enhancing patients' access to care and medications for neurological illnesses.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Neurology Device Market Segmentation

The Neurology Device Market is segmented as mentioned below:

By Product Type (Revenue, USD Billion):

Neurostimulation
?Spinal Cord Stimulation Devices
Deep Brain Stimulation Devices
Sacral Nerve Stimulation
Vagus Nerve Stimulation
Gastric Electric Stimulation
Interventional Neurology
- Aneurysm Coiling & Embolization
- Embolic Coils
- Flow Diversion Devices
- Liquid Embolic Agents
- Cerebral Balloon Angioplasty & Stenting
- Carotid Artery Stents
- Filter Devices
- Balloon Occlusion Devices
- Neurothrombectomy
- Clot Retriever
- Suction Aspiration Devices
- Snares
CSF Management
- CSF Shunts
- CSF Drainage
Neurosurgery Devices
- Ultrasonic Aspirators
- Stereotactic Systems
- Neuroendoscopes
- Aneurysm Clips

By End User (Revenue, USD Billion):

??Hospitals and Clinics
Specialty Centres
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.

To request a free sample copy of this report, please complete the form below.

We value your inquiry and offer free customization with every report to fulfil your exact research needs.

Yes, I have read the privacy policy

The market is segmented by product type and by end-user.

The Argentina Neurology devices market is studied from 2022-2030.

Johnson and Johnson, GE Healthcare, Stryker, Medtronic, Abbott Laboratories and Philips Healthcare are the major companies operating in Argentina's neurology devices market.